Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 999-1004

  Frasa, Lma ^a   Benaissa Trouw, Barry ^a   Tavares, Luis ^a   Van Kessel, Kok ^a   Hustinx, Willem ^a   Schellekens, Joop ^a   Kraaijeveld, Kees ^a   Verhoef, Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPENEM; IMMUNOGLOBULIN M ANTIBODY; LIPID A; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; BACTEREMIA; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; INFECTION PREVENTION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 9244235477     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.999     Document Type: Article

References (31)

1. Baumgartner, J. D., D. Heumann, J. Gerain, P. Weinbreck, G. E. Grau, and M. P. Glauser. 1990. Association between protective efficacy of and-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor αand intericukin 6. J. Exp. Med. 171:889-896.
2. Bogard, W. C., D. L. Dunn, K. Abernethy, C. Kilgarriff, and P. C. Kung. 1987. Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity. Infect Immun. 55:899-908.
3. Chopra, I., and A. Linton. 1986 The antibacterial effects of low concentrations of antibiotics Adv Microb. Physiol. 28:211-259.
4. Cornelissen, J. J., I. Makel, A. Algra, B. J. Benaissa-Tronw, J. F. P. Schellens, C. A. Kraaijeveld, and J. Verhoef. 1993. Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies, comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A. J. Infect. Dis. 167:876-881.
5. Cornelissen, J. J., C. P. M. Van Kessel, E. Brouwer, C. A. Kraaijeveld, and J. Verhoef. 1991 Inhibition by lipid A-specific monoclonal antibodies of priming of human polymorphonuclear leucocytes by endotoxin. J. Med Microbiol 34:233-238.
6. Cross, A. S., S. M. Opal, J. E. Palardy, M. W. Bodmer, and J. C. Sadoff. 1993. The efficacy of combination immunotherapy in experimental Pseudomonas sepsis. J. Infect. Dis. 167:112-118.
7. Cross, A. S., S. M. Opal, J. C. Sadoff, and P. Gemski. 1993. Choice of bacteria in animal models of sepsis. Infect Immun. 61:2741-2747.
8. Dofferhoff, A. S. M., J. H. Nijland, H. G. de Vries-Hospers, P. O. M. Mulder, J. Weits, and V. J. J. Bom. 1991. Effects of different types and combinations of antimicrobial agents on endotoxin release from gtam-negative bacteria: an in-vitro and in-vivo study. Scand. J Infect. Dis 23:745-754
9. Edmond, D. M., I. R. Poxton, and F. di Padova. 1993. The accessibility of cross-reactive anti-lipopolysaccharide-core monoclonal antibodies to Escherichia coli in sub-MICs of temocillin and other antibiotics J. Antimicrob Chemother. 31:673-680
10. Erich, T., J. Schellekens, A. Bouter, J. van Kranen, E. Brouwer, and J. Verhoef. 1989 Binding characteristics and cross-reactivity of three different antilipid A monoclonal antibodies. J. Immunol 143:4053-4060.
11. Evans, M. E., M. Pollack, N. J. Hardegen, N. L. Koles, G. Guelde, and J. K. S. Chia. 1990. Fluorescence-activated cell sorter analysis of binding by lipopolysaccharide-specific monoclonal antibodies to gram-negative bacteria. J Infect. Dis. 162:148-155.
12. Frasa, H., B. Benaissa-Trouw, K. Van Kessel, M. Poppelier, L. Tavares, K. Kraaijeveld, and J. Verhoef. 1996. Enhanced protection by use of a combination of anti-capsule and anti-lipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice. Infect. Immun 64:775-781.
13. Frasa, H., J. Procee, R. Torensma, A. Verbruggen, A. Algra, M. Rozenberg-Arska, K. Kraaijeveld, and J. Verhoef. 1993. Escherichia coli in bacteremia O-acetylated K1 strains appear to be more virulent than non-O-acetylated K1 strains. J. Clin. Microbiol. 31:3174-3178.
14. Friedland, I. R., H. Jafari, S. Ehrett, S. Rinderknecht, M. Paris, M. Coulthard, H. Saxen, K. Olsen, and G. H. McCracken. 1993. Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis J. Infect Dis 168:657-662.
15. Gaily, P., D. Heumann, D. L. le Roy, C. Barras, and M. P. Glauser. 1993. Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock. Proc. Natl. Acad. Sci. USA 90:9935-9938.
16. Gigliotti, F., and J. L. Shenep. 1985. Failure of monoclonal antibodies to core glycolipid to bind to intact smooth strains of Eschenchia coli. J. Infect. Dis. 151:1005-1011.
17. Greisman, S. E., and C. A. Johnston. 1988. Failure of antisera to J5 and R595 rough mutants to reduce endotoxemic lethality. J. Infect. Dis 157:54-64
18. Heumann, D., P. Gallay, S. B. Betz-Corradin, C. Barras, J. D. Baumgartner, and M. P. Glauser. 1993. Competition between bactericidal/permeability protein for lipopolysaccharide binding to monocytes J. Infect. Dis 167: 1351-1357.
19. Hoffman, W. D., M. Pollack, S. M. Banks, L. A. Koev, M. A. Solomon, R. L. Danner, N. Koles, G. Guelde, I. Yatsiv, T. Mouginis, R. J. Elin, J. M. Hosseini, J. Bacher, J. C. Porter, and C. Natanson. 1994. Distinct functional activities in canine septic shock of monoclonal antibodies specific for the O lysaccharide and core regions of Escherichia coli lipopolysaccharide. J. Infect. Dis 169:553-561.
20. Hurley, J. C. 1992. Antibiotic-induced release of endotoxin: a reappraisal. Clin. Infect. Dis. 15:840-854.
21. Jackson, J. J., and H. Kropp. 1992. β-Lactam antibiotic-induced release of free endotoxin: in-vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J. Infect. Dis 165:1033-1041.
22. Jacques, M., A. Lebrun, B. Foiry, M. Dargis, and F. Malouin. 1991. Effects of antibiotics on the growth and morphology of Pasteurella multocida. J. Gen. Microbiol. 137:2663-2668.
23. Kreyzig, E. Introductionary mathematical statistics, p. 339. John Wiley & Sons, Inc., New York.
24. Lorain, V., and J. Ernst. 1987. Effects of antibiotics on bacterial structure and their pathogeniciry. Pathol. Biol. 35:1370-3176.
25. Nelson, D., T. E. S. Delahooke, and I. R. Poxton. 1993. Influence of subinhibitory levels of antibiotics on expression of Escherichia coli lipopolysaccharide and binding of anti-lipopolysaccharide monoclonal antibodies J. Med. Microbiol. 39:100-106.
26. Overbeek, B. P., N. M. de Vos, N. Keller, G. Raponi, M. Rozenberg-Arska, and J. Verhoef. 1989. Enhanced binding of murine monoclonal antibodies to lipopolysaccharide structures of Enterobacteriaceae after treatment with an-tibiotics. Serodiagn. Immunother. Infect. Dis. 3:167-174.
27. Overbeek, B. P., and E. M. Veringa. 1991. Role of antibodies and antibiotics in aerobic gram-negative septicemia: possible synergism between antimicrobial treatment and immunotherapy. Rev. Infect. Dis. 13:751-760.
28. Quezado, Z. M. N., C. Natanson, D. W. Ailing et al. 1993. A controlled trial of HA-1A in a canine model of gram-negative septic shock. JAMA 269: 2221-2227.
29. Raponi, G., N. Keller, B. P. Overbeek, M. Rozenberg-Arska, K. P. M. van Kessel, and J. Verhoef. 1990. Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface. Antimicrob. Agents Chemother. 34: 332-336.
30. Tarleton, R. L., and A. M. Beyer. 1991. Medium-scale production and purification of monoclonal antibodies in protein-free medium. BioTechniques 11:590-593.
31. Wright, S. D. 1991. Multiple receptors Curr. Opin. Immunol. 3:83-90.